Dr. Miguel-Angel Perales

Miguel-Angel Perales, MD

Bone Marrow Transplant Specialist & Cellular Therapist

Areas of Expertise

Conditions I Treat

  • Leukemia
  • Blood, bone marrow, and hematologic cancers and conditions
  • Myelodysplastic syndrome (MDS)

My Specialties

  • Bone marrow transplant
  • Immunotherapy
  • Cancer vaccines
View more expertise
Dr. Perales's Office Information
Languages: English, French, and Spanish
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

I am a board-certified medical oncologist with expertise in donor-derived hematopoietic (blood-forming) stem cell transplantation. Hematopoietic stem cells from a donor other than the patient can cure many patients who have diseases of the blood and bone marrow, including leukemias and lymphomas. The donor stem cells can come from different sources (related or unrelated donors, and bone marrow, peripheral blood, or umbilical cord blood units) and can be modified in different ways before transplantation to enhance their effectiveness.

Along with colleagues here, I am participating in a number of studies designed to improve outcomes in patients undergoing stem cell transplantation, including finding ways to lower the risk of complications, relapse, and graft-versus-host disease. In particular, I am leading a clinical trial in patients who have advanced Hodgkin lymphoma; the goal of the trial is to determine the safest way to perform a transplant using stem cells from a donor in patients with relapsed Hodgkin lymphoma.

I also conduct translational clinical research investigating new ways to enhance the recovery of the immune system after a transplant and ways to help the immune system fight hematologic malignancies. My colleagues and I are investigating new agents such as interleukin-7 and KGF to enhance immune recovery, as well as new approaches to generate specialized T cells that will specifically target hematologic malignancies.

My practice consists of patients with a variety of hematologic malignancies who are in need of an allogeneic transplant, including patients with acute myelogenous leukemia, acute lymphoblastic leukemia, myelodysplastic syndromes, chronic lymphocytic leukemia, non-Hodgkin lymphoma, and Hodgkin lymphoma. The goal of my practice and clinical research is to be able to offer every patient in need of a transplant the opportunity to undergo this potentially curative therapy.

What I Do at MSK

I'm a bone marrow transplant specialist, which is a doctor with special training in bone marrow transplants.

A cellular therapy specialist is a doctor with special training in using cell therapies to treat health conditions such as cancer. Therapies can include chimeric antigen receptor (CAR) T cell therapy.

  • Chief, Adult Bone Marrow Transplant Service
Areas of Expertise

Conditions I Treat

  • Leukemia
  • Blood, bone marrow, and hematologic cancers and conditions
  • Myelodysplastic syndrome (MDS)
  • Lymphoma
  • Multiple myeloma and other plasma-cell diseases
  • Acute myeloid leukemia (AML)
  • Acute lymphocytic leukemia (ALL)
  • Chronic lymphocytic leukemia (CLL)
  • Hodgkin lymphoma (Hodgkin’s disease)
  • Non-Hodgkin lymphoma (NHL)

My Specialties

  • Bone marrow transplant
  • Immunotherapy
  • Cancer vaccines
  • CAR T-cell therapy
  • Cellular therapy
  • Clinical trials
Education & Honors

Education

  • MD, Free University of Brussels

Residencies

  • Internal Medicine, Tufts-New England Medical Center

Fellowships

  • Medical Oncology/Hematology, Memorial Sloan Kettering Cancer Center
  • Medicine, Weill Cornell Medical College

Board Certifications

  • Internal Medicine, Medical Oncology

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking
New Patients
Scheduling an appointment is easy. Click or call 877-836-ABMT (2268)— we’re available 24 hours a day, 7 days a week
Make an Appointment
Current Patients
Request an appointment by calling your Care Team or messaging them in MSK MyChart.

Contact and Location

Office Phone
Location
New York, NY
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
530 East 74th Street New York NY 10021
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Bone Marrow Transplant Service doctors

See all Cellular Therapy Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Perales’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Miguel-Angel Perales discloses the following relationships and financial interests:

  • Allogene Therapeutics
    Professional Services and Activities (Uncompensated)
  • Bristol-Myers Squibb
    Professional Services and Activities
  • Celgene
    Professional Services and Activities (Uncompensated)
  • Cidara Therapeutics, Inc.
    Professional Services and Activities
  • Incyte
    Professional Services and Activities (Uncompensated)
  • Kite Pharmaceuticals
    Professional Services and Activities
  • Merck & Co Inc.
    Professional Services and Activities
  • Miltenyi Biotec Incorporated
    Professional Services and Activities
  • Novartis
    Professional Services and Activities (Uncompensated)
  • Omeros
    Equity; Professional Services and Activities
  • Orca Biosystems, Inc.
    Equity; Professional Services and Activities
  • Pierre Fabre
    Professional Services and Activities
  • Sanofi S.A.
    Professional Services and Activities
  • Sellas Life Science Group
    Professional Services and Activities
  • Takeda Pharmaceuticals
    Professional Services and Activities
  • Vor Biopharma Inc.
    Professional Services and Activities (Uncompensated)

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures

Related topics: